Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThames Wat.u 35 Regulatory News (AW14)

Share Price Information for Thames Wat.u 35 (AW14)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
AW14 Live PriceLast checked at - London Stock Exchange

Intraday Thames Wat.u 35 Share Chart

CMA and Equity Raise Update

18 Mar 2025 12:25

RNS Number : 1544B
Thames Water Utilities Limited
18 March 2025
 

Thames Water Utilities Limited

18 March 2025

CMA and Equity Raise Update

 

CMA Reference Deferral Process

Thames Water Utilities Limited ("TWUL" or the "Company") announced on 14 February 2025 that it had asked its economic regulator, Ofwat, to refer its Final Determination to the Competition and Markets Authority (CMA) for a re-determination (the "Reference"). 

 

TWUL and Ofwat have now agreed that Ofwat will defer making the Reference for a period of up to 18 weeks from 18 March 2025.

 

This deferral is not a withdrawal of the request for the Reference and TWUL remains of the view that the Final Determination does not serve the interests of Thames Water's customers, communities and the environment.

 

However, TWUL has concluded that recent discussions hold out the prospect of unlocking a market led solution for the recapitalisation of the Company, including through an equity raise, without the need for a CMA reference.

 

Sir Adrian Montague, Chairman Thames Water said: "We appreciate Ofwat's time and constructive approach to our recent discussions and look forward to working with Ofwat and our other stakeholders over the next few months to achieve our shared goal of a sustainable recapitalisation of the Company, so that it may better serve its customers and stakeholders for decades to come."

 

Equity Raise Process

Following our announcement on 11 February 2025, we are providing a further update on our equity raise process.

TWUL received proposals from six parties in respect of the equity raise process launched by the Company in the summer of 2024, and has since been conducting a detailed assessment of each proposal. The Company continues to target having agreed transaction terms in the second quarter of 2025, with a view to completing a recapitalisation in the third quarter of 2025. 

The proposals involve a range of potential valuations, structures and outcomes for stakeholders. Of the five proposals that provided financial metrics, all except one (from a Class B Creditor and with significant conditions attached) indicated a material impairment of the Class A debt. The sixth proposal was for minority equity, intended to partner with investors, and did not set out financial metrics. 

In certain of the contemplated proposals, relevant creditors would receive - in exchange for debt impairment - certain rights to share in future growth in the value of the Company, and/or will have the ability to co-invest in the business.

Most proposals are conditional on further, and varying, regulatory support and accommodations being achieved which the Company intends to progress in the coming months as part of its efforts to achieve a sustainable recapitalisation.

Discussions with relevant parties are ongoing, although there is no certainty that a binding equity proposal will be forthcoming or that any such proposals will be capable of being implemented. As a result, certain senior creditors continue to progress in parallel alternative transaction structures to seek to recapitalise the business.

For further information

Investor enquiries

Edwin Lloyd - Head of Investor Relations debt.investorrelations@thameswater.co.uk

Media enquiries

Suvra Jans - Head of Media Relations 07747 640810

Suvra.jans@thameswater.co.uk

Alex Simmons thameswater@edelmansmithfield.com 

LEI: 213800JKM5UQHFJOTZ25

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDZZGMFZRMGKZM
12
Date   Source Headline
5th Jun 202610:01 amRNSEleventh Consent Requests - Super Senior Funding
3rd Jun 20269:07 amRNSResults of Tenth Consent Request
18th May 202610:05 amRNSTenth Consent Request - Super Senior Funding
24th Apr 20269:00 amRNSResults of Ninth Consent Requests
9th Apr 202610:00 amRNSNinth Consent Requests - Super Senior Funding
17th Mar 20261:29 pmRNSResults of Eighth Consent Requests & STID Proposal
16th Mar 20267:00 amRNSRecapitalisation Update on L&VW’s Proposal
2nd Mar 20262:22 pmRNSEighth Consent Requests and STID Proposal
12th Feb 20269:00 amRNSLiquidity Extension Update
8th Jan 202610:22 amRNSResults of Seventh Consent Requests
19th Dec 202511:41 amRNSSeventh Consent Requests - Super Senior Funding
19th Dec 202510:30 amRNSResults of STID Proposals & Sixth Consent Requests
4th Dec 20252:53 pmRNSSTID Proposals and Sixth Consent Requests
3rd Dec 20257:14 amRNSInterim Financial Statements
3rd Dec 20257:00 amRNSInterim Financial Statements
24th Nov 20259:00 amRNSFifth Consent Requests (Results)
10th Nov 20259:00 amRNSFifth Consent Requests - Super Senior Funding
21st Oct 202510:00 amRNSCMA Reference Deferral Update
9th Oct 20252:45 pmRNSRecapitalisation Update - Class B Ad Hoc Group
22nd Sep 202510:06 amRNSTWUL - Fourth Consent Requests (Results)
5th Sep 202511:00 amRNSFourth Consent Requests - Super Senior Funding
27th Aug 20257:00 amRNSInvestigations Update - Payment Plan
15th Aug 20257:00 amRNSLiquidity Extension Update
23rd Jul 20257:00 amRNSAnnual Financial Report
22nd Jul 20257:00 amRNSAnnual Financial Report
18th Jul 20252:44 pmRNSCMA Reference Deferral Update
15th Jul 20257:01 amRNSAnnual Financial Report
15th Jul 20257:00 amRNSResults of the Third Consent Requests
30th Jun 202511:03 amRNSThird Consent Requests Super Senior Issuer Funding
3rd Jun 20257:00 amRNSEquity Raise Update
28th May 20257:10 amRNSInvestigations Update
14th May 20251:07 pmRNSResults of the Second Consent Requests
28th Apr 20252:05 pmRNSSecond Super Senior Funding Waiver Consent Request
2nd Apr 202512:00 pmRNSThames Water appoints new Chief Financial Officer
1st Apr 20255:13 pmRNSResults of STID Proposal and Consent Requests
31st Mar 20257:00 amRNSEquity Raise Update
28th Mar 202512:00 pmRNSThames Water Chief Financial Officer Steps Down
18th Mar 202512:25 pmRNSCMA and Equity Raise Update
17th Mar 20253:10 pmRNSTWUL - Update on Super Senior Funding Waiver
17th Mar 202511:16 amRNSRestructuring Plan Upheld
21st Feb 20254:18 pmRNSNotice of Plan Effective Date
18th Feb 20259:30 amRNSRestructuring Plan Sanctioned
14th Feb 20257:00 amRNSTWUL - Referral of Final Determination to CMA
11th Feb 20252:35 pmRNSEquity Raise Process Update
10th Feb 202511:37 amRNSTWUL - STID Proposal Results
31st Jan 20253:56 pmRNSLiquidity Extension Update - Sanction Hearing
24th Jan 20253:43 pmRNSLiquidity Extension Update
22nd Jan 20254:24 pmRNSLiquidity Extension Update
10th Jan 20254:37 pmRNSTWUL - STID Proposal Results
7th Jan 20254:24 pmRNSLiquidity Extension Update
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.